Yayın: Are pretreatment inflammation-based prognostic scores useful in predicting the outcomes of patients with ALK-positive NSCLC?
| dc.contributor.author | Ölmez, O. F. | |
| dc.contributor.author | Bilici, A. | |
| dc.contributor.author | Gürsoy, P. | |
| dc.contributor.author | Çubukcu, Erdem | |
| dc.contributor.author | Yıldız, O. | |
| dc.contributor.author | Sakin, A. | |
| dc.contributor.author | Korkmaz, T. | |
| dc.contributor.author | Çil, I. | |
| dc.contributor.author | Çakar, B. | |
| dc.contributor.author | Menekşe, S. | |
| dc.contributor.author | Demir, T. | |
| dc.contributor.author | Açıkgöz, O. | |
| dc.contributor.author | Hamdard, J. | |
| dc.contributor.buuauthor | ÇUBUKÇU, ERDEM | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Tıbbi Onkoloji | |
| dc.contributor.researcherid | JGT-4101-2023 | |
| dc.date.accessioned | 2024-11-19T10:49:06Z | |
| dc.date.available | 2024-11-19T10:49:06Z | |
| dc.date.issued | 2019-10-01 | |
| dc.identifier.eissn | 1556-1380 | |
| dc.identifier.endpage | S552 | |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.issue | 10 | |
| dc.identifier.startpage | S551 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S1556086419318350 | |
| dc.identifier.uri | https://hdl.handle.net/11452/48093 | |
| dc.identifier.volume | 14 | |
| dc.identifier.wos | 000492162203068 | |
| dc.indexed.wos | WOS.SCI | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.journal | Journal of Thoracic Oncology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Inflammation-based prognostic scores | |
| dc.subject | Non small cell lung cancer | |
| dc.subject | Anaplastic lymphoma kinase | |
| dc.subject | Science & technology | |
| dc.subject | Life sciences & biomedicine | |
| dc.subject | Oncology | |
| dc.subject | Respiratory system | |
| dc.title | Are pretreatment inflammation-based prognostic scores useful in predicting the outcomes of patients with ALK-positive NSCLC? | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Tıbbi Onkoloji | |
| local.indexed.at | WOS | |
| relation.isAuthorOfPublication | f971677f-09c5-4463-bf01-3c6341fbe5f7 | |
| relation.isAuthorOfPublication.latestForDiscovery | f971677f-09c5-4463-bf01-3c6341fbe5f7 |
Dosyalar
Orijinal seri
1 - 1 / 1
